BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35097193)

  • 1. Transient Central Diabetes Insipidus Occurring After Vasopressin Infusion.
    Cristiano EA; Harris A; Grdinovac K
    AACE Clin Case Rep; 2022; 8(1):8-10. PubMed ID: 35097193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
    Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
    Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rare Case of Familial Neurogenic Diabetes Insipidus in a 22-Year-Old Man.
    Phan VTT; Bloomer ZW; Phan VTX; Shakir MKM; Hoang TD
    AACE Clin Case Rep; 2021; 7(6):338-341. PubMed ID: 34765727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin Bolus Protocol Compared to Desmopressin (DDAVP) for Managing Acute, Postoperative Central Diabetes Insipidus and Hypovolemic Shock.
    Shukla A; Alqadri S; Ausmus A; Bell R; Nattanmai P; Newey CR
    Case Rep Endocrinol; 2017; 2017():3052102. PubMed ID: 28127476
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of central diabetes insipidus after ketamine infusion during an external to internal carotid artery bypass.
    Gaffar S; Eskander JP; Beakley BD; McClure BP; Amenta P; Pierre N
    J Clin Anesth; 2017 Feb; 36():72-75. PubMed ID: 28183578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of transient central diabetes insipidus with intravenous desmopressin in a premature infant with gastroschisis and septo-optic dysplasia: A case report.
    Kim F; Towers HM
    J Neonatal Perinatal Med; 2021; 14(2):293-297. PubMed ID: 32804104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A COMBINED OUTPATIENT AND INPATIENT OVERNIGHT WATER DEPRIVATION TEST IS EFFECTIVE AND SAFE IN DIAGNOSING PATIENTS WITH POLYURIA-POLYDIPSIA SYNDROME.
    Pedrosa W; Drummond JB; Soares BS; Ribeiro-Oliveira A
    Endocr Pract; 2018 Nov; 24(11):963-972. PubMed ID: 30106630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.
    Decaux G; Prospert F; Namias B; Soupart A
    Am J Med; 1997 Nov; 103(5):376-82. PubMed ID: 9375705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient Diabetes Insipidus After Discontinuation of Vasopressin in Neurological Intensive Care Unit Patients: Case Series and Literature Review.
    Bohl MA; Forseth J; Nakaji P
    World Neurosurg; 2017 Jan; 97():479-488. PubMed ID: 27742514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapy.
    Deligiorgi MV; Siasos G; Vergadis C; Trafalis DT
    Int Immunopharmacol; 2020 Jun; 83():106427. PubMed ID: 32244049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide secretion was not directly affected by arginine vasopressin in diabetes insipidus.
    Shimizu H; Tanaka Y; Nakamura K; Uehara Y; Shimomura Y
    J Med; 1991; 22(4-5):299-305. PubMed ID: 1838565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central diabetes insipidus and partial anterior pituitary dysfunction in acute myeloid leukemia.
    Arya R; Ahmad T; Dash S
    Endocrinol Diabetes Metab Case Rep; 2022 Jul; 2022():. PubMed ID: 37931409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnant woman with transient diabetes insipidus resistant to 1-desamino-8-D-arginine vasopressin.
    Jin-no Y; Kamiya Y; Okada M; Watanabe O; Ogasawara M; Fujinami T
    Endocr J; 1998 Oct; 45(5):693-6. PubMed ID: 10395251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient Central Diabetes Insipidus after Discontinuation of Vasopressin.
    Carman N; Kay C; Petersen A; Kravchenko M; Tate J
    Case Rep Endocrinol; 2019; 2019():4189525. PubMed ID: 31885944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
    Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
    Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gradient washout and secondary nephrogenic diabetes insipidus after brain injury in an infant: a case report.
    Chang N; Mariano K; Ganesan L; Cooper H; Kuo K
    J Med Case Rep; 2020 Oct; 14(1):183. PubMed ID: 33036650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of DDAVP on nocturnal enuresis in a patient with nephrogenic diabetes insipidus.
    Jonat S; Santer R; Schneppenheim R; Obser T; Eggert P
    Arch Dis Child; 1999 Jul; 81(1):57-9. PubMed ID: 10373137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pregnant Woman with Excess Vasopressinase-Induced Diabetes Insipidus Complicated by Central Diabetes Insipidus like Lymphocytic Infundibulo-Neurohypophysitis.
    Yanagisawa S; Oikawa Y; Endo M; Inoue K; Nakajima R; Yasuda S; Sato M; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Isshiki M; Shimada A
    Case Rep Endocrinol; 2024; 2024():8687054. PubMed ID: 38646198
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.